sodium thiosulfate has been researched along with Deafness, Transitory in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 8 (38.10) | 2.80 |
| Authors | Studies |
|---|---|
| Hazlitt, RA; Min, J; Zuo, J | 1 |
| Esbenshade, A; Freyer, DR; Krailo, MD; Orgel, E; Sung, L; Villaluna, D | 1 |
| Freyer, DR; Knight, K; Krailo, M; Orgel, E | 1 |
| Brock, PR; Cabral, S; Chang, KW; Dupuis, LL; Epelman, S; Freyer, DR; Knight, K; Mills, D; Phillips, R; Potter, E; Risby, D; Robinson, PD; Simpkin, P; Sullivan, M; Sung, L | 1 |
| Hu, QY; Keilty, J; Kropp, J; McCarthy, R; Ren, Y; Shi, F; Soglia, J; Viglietta, V; Weber, P; Wolff, H | 1 |
| Boyce, AM; Ferreira, CR; Gafni, RI | 1 |
| Dvorak, CC; Esbenshade, AJ; Freyer, DR; Hardy, KK; Orgel, E; Thomas, SM; Ullrich, NJ | 1 |
| Harao, T; Kamimura, S; Kinoshita, M; Moritake, H; Yamada, A | 1 |
| Balm, AJM; Beijnen, JH; Burgers, JA; de Boer, JP; de Weger, VA; Dreschler, WA; Duinkerken, CW; Hauptmann, M; Marchetti, S; Nuijen, B; Pluim, D; Rosing, H; Schellens, JHM; van der Molen, L; Zuur, CL | 1 |
| Ansari, M; Brichard, B; Brock, PR; Brugières, L; Capra, M; Childs, M; Covezzoli, A; Czauderna, P; Dall'Igna, P; Hiyama, E; Laithier, V; Maibach, R; Mateos, ME; Morland, B; Neuwelt, EA; Perilongo, G; Rajput, K; Rangaswami, AA; Rechnitzer, C; Roebuck, D; Ronghe, M; Skeen, J; Sullivan, MJ; Veal, GJ | 1 |
| Killock, D | 1 |
| Brock, PR; Maibach, R; Neuwelt, EA | 1 |
| Frazier, AL; Freyer, DR; Sung, L | 1 |
| Bairati, I; Bussières, R; Côté, M; Guitton, MJ; Leclerc, M; Meyer, F; Philippon, D; Rolland, V | 1 |
| Endo, K; Hatano, M; Ishikawa, E; Ito, M; Kondo, S; Murono, S; Nakanishi, Y; Sugimoto, H; Tsuji, A; Wakisaka, N; Yoshizaki, T | 1 |
| Bliss, B; Chen, L; Freyer, DR; Knight, K; Krailo, MD; Lange, B; Neuwelt, EA; Pollock, BH; Ramdas, J; Sung, L; Van Hoff, D; VanSoelen, ML; Villaluna, D; Wiernikowski, J | 1 |
| Sullivan, MJ | 1 |
| Blakley, BW; Campbell, KC; Cohen, JI; Dickey, DT; Doolittle, ND; Muldoon, LL; Neuwelt, EA | 1 |
| Fetoni, A; Guitton, MJ; Lloyd Faulconbridge, RV; Puel, JL; Pujol, R; Wang, J | 1 |
| Begleiter, A; Blakley, BW; Leith, MK; Viallet, NR | 1 |
| Balm, AJ; Dreschler, WA; Hart, AA; Lansdaal, PE; Rasch, CR; Schornagel, JH; Simis, YJ; Zuur, CL | 1 |
4 review(s) available for sodium thiosulfate and Deafness, Transitory
| Article | Year |
|---|---|
Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss.
Topics: Animals; Cisplatin; Drug Discovery; Hearing Loss; Humans | 2018 |
Special considerations in the design and implementation of pediatric otoprotection trials.
Topics: Antineoplastic Agents; Cancer Survivors; Carboplatin; Child; Cisplatin; Hearing Loss; Humans; Quality of Life | 2023 |
Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.
Topics: Adolescent; Antineoplastic Agents; Child; Cisplatin; Female; Hearing Loss; Humans; Male; Neoplasms; Ototoxicity; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Thiosulfates | 2020 |
Generalized Arterial Calcification of Infancy: New Insights, Controversies, and Approach to Management.
Topics: Adenosine Monophosphate; Bone Density Conservation Agents; Calcinosis; Cardiovascular Agents; Chelating Agents; Diphosphates; Diphosphonates; Familial Hypophosphatemic Rickets; Genotype; Hearing Loss; Humans; Multidrug Resistance-Associated Proteins; Phenotype; Phosphoric Diester Hydrolases; Pseudoxanthoma Elasticum; Pyrophosphatases; Thiosulfates; Tooth Diseases; Vascular Calcification; Vitamin D | 2020 |
6 trial(s) available for sodium thiosulfate and Deafness, Transitory
| Article | Year |
|---|---|
Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients.
Topics: Adult; Antineoplastic Agents; Cisplatin; Double-Blind Method; Female; Healthy Volunteers; Hearing Loss; Humans; Injection, Intratympanic; Male; Middle Aged; Neoplasms; Thiosulfates; Young Adult | 2020 |
Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial.
Topics: Adult; Antineoplastic Agents; Cisplatin; Hearing Loss; Humans; Thiosulfates | 2021 |
Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
Topics: Adolescent; Child; Child, Preschool; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Hearing Loss; Hepatoblastoma; Humans; Incidence; Infant; Liver Neoplasms; Male; Single-Blind Method; Survival Analysis; Thiosulfates | 2018 |
A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
Topics: Aged; Antineoplastic Agents; Antioxidants; Carcinoma, Squamous Cell; Cisplatin; Female; Head and Neck Neoplasms; Hearing Loss; Humans; Injection, Intratympanic; Male; Middle Aged; Thiosulfates; Treatment Outcome | 2019 |
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.
Topics: Adolescent; Antineoplastic Agents; Antioxidants; Child; Child, Preschool; Cisplatin; Drug Therapy, Combination; Female; Follow-Up Studies; Hearing Loss; Humans; Incidence; Infant; Male; Neoplasm Staging; Neoplasms; Prognosis; Survival Rate; Thiosulfates; United States | 2017 |
Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Topics: Antineoplastic Agents; Auditory Threshold; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Ear, Inner; Female; Head and Neck Neoplasms; Hearing Loss; Hearing Loss, Sensorineural; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Radiotherapy Dosage; Thiosulfates | 2007 |
11 other study(ies) available for sodium thiosulfate and Deafness, Transitory
| Article | Year |
|---|---|
Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431.
Topics: Cisplatin; Hearing Loss; Humans; Thiosulfates | 2022 |
Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey.
Topics: Adolescent; Antineoplastic Agents; Antioxidants; Child; Cisplatin; Follow-Up Studies; Hearing Loss; Humans; Neoplasms; Prognosis; Surveys and Questionnaires; Thiosulfates | 2020 |
Prevention of cisplatin-induced hearing-loss by sodium thiosulfate in medulloblastoma.
Topics: Antineoplastic Agents; Cerebellar Neoplasms; Cisplatin; Hearing Loss; Humans; Medulloblastoma; Thiosulfates | 2020 |
Sodium thiosulfate halves the risk of cisplatin-induced hearing loss.
Topics: Cisplatin; Hearing Loss; Humans; Thiosulfates | 2018 |
Sodium Thiosulfate and Cisplatin-Induced Hearing Loss.
Topics: Antineoplastic Agents; Cisplatin; Deafness; Hearing Loss; Humans; Thiosulfates | 2018 |
Sodium Thiosulfate and Cisplatin-Induced Hearing Loss.
Topics: Antineoplastic Agents; Cisplatin; Deafness; Hearing Loss; Humans; Thiosulfates | 2018 |
Protective effects of sodium thiosulfate for cisplatin-mediated ototoxicity in patients with head and neck cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chelating Agents; Chemoradiotherapy; Cisplatin; Cohort Studies; Female; Head and Neck Neoplasms; Hearing Loss; Humans; Incidence; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Squamous Cell Carcinoma of Head and Neck; Thiosulfates | 2015 |
Hepatoblastoma, cisplatin, and ototoxicity: good news on deaf ears.
Topics: Amifostine; Cisplatin; Clinical Trials as Topic; Hearing Loss; Hepatoblastoma; Humans; Infant; International Cooperation; Liver Neoplasms; Research Design; Thiosulfates; Treatment Outcome | 2009 |
Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001.
Topics: Animals; Antineoplastic Agents; Antioxidants; Blood-Brain Barrier; Carboplatin; Cisplatin; Head and Neck Neoplasms; Hearing Loss; Humans; Methionine; Platinum Compounds; Thiosulfates | 2002 |
Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig.
Topics: Action Potentials; Animals; Cell Death; Cisplatin; Cochlea; Cytochrome c Group; Female; Guinea Pigs; Hearing Loss; Infusion Pumps, Implantable; Organ of Corti; Thiosulfates | 2003 |
Effect of sodium thiosulphate and cis-diamminedichloroplatinum on FADU tumour cells in nude mice.
Topics: Animals; Antineoplastic Agents; Antioxidants; Carcinoma, Squamous Cell; Cisplatin; Disease Models, Animal; Drug Interactions; Female; Hearing Loss; Humans; Kidney Diseases; Mice; Mice, Nude; Neoplasm Transplantation; Random Allocation; Stomach Neoplasms; Thiosulfates; Treatment Outcome | 2005 |